The Healthcare Stage I Episode 6 I Applying precision oncology to study the effect of anesthetic and analgesic drug on cancer outcomes

In this episode, we're zeroing in on how precision oncology principles are revolutionizing our understanding of anesthetic and analgesic drugs and their potential influence on cancer outcomes. My guest, Professor Joshua Mincer from the Memorial Sloan Kettering Cancer Center in New York, unveils cutting-edge research applying these principles to gauge the effects of anesthetics and painkillers on cancer patient outcomes, viewed through the prism of patient-specific omics data. This line of research is particularly important since most anesthetic and anti-pain medications are generic drugs, hinting at the possibility of boosting patient outcomes without the burden of extra costs. Moreover, we'll explore the horizon of clinical development for innovative anti-pain and anticancer immunotherapies and delve into the critical evaluations needed for the combined use of new anticancer and pain management drugs, aiming to illuminate the future pathways for improving cancer outcomes."

 

The podcast episodes are available at The Healthcare Stage YouTube channel, on Spotify and Apple podcast:
https://www.youtube.com/@TheHealthcareStage

https://open.spotify.com/show/0e3gsjyULZCSLlpR9hx4PR

https://podcasts.apple.com/il/podcast/the-healthcare-stage/id1723753563

 

#TheHealthCareStage #Percisionmedicine #cancer #MSK #Analgesics #anasthetics #antipainmedication #Oncology